Radnostix, Inc. (INIS)
OTCMKTS · Delayed Price · Currency is USD
0.0711
+0.0011 (1.57%)
Jun 2, 2026, 10:30 AM EST

Revenue by Segment

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Theranostics Products
6.84M8.01M6.84M6.05M4.28M
Theranostics Products Growth
-14.55%17.00%13.18%41.42%5.00%
Cobalt Products
1.75M2.37M1.04M1.16M1.35M
Cobalt Products Growth
-25.93%128.10%-10.41%-14.54%10.52%
Calibration & Reference Products
4.25M3.52M4.39M3.98M-
Calibration & Reference Products Growth
20.71%-19.79%10.27%--
Medical Device Products
228.95K8.66K---
Medical Device Products Growth
2544.69%----
Fluorine Products
----29.78K
Fluorine Products Growth
-----83.31%
Nuclear Medicine Standards
----4.00M
Nuclear Medicine Standards Growth
----8.97%
Total
13.07M13.90M12.27M11.18M9.66M
Total Growth
-5.97%13.31%9.71%15.73%3.17%

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
United States
9.65M8.20M
United States Growth
17.68%1.41%
outside United States
1.53M1.46M
outside United States Growth
4.79%14.29%
Total
11.18M9.66M
Total Growth
15.73%3.17%
Source: S&P Global Market Intelligence.